FILING ANALYSIS · THURSDAY, AUGUST 6

Carl Zeiss Meditec Ag 0DHC — RNS

neutral

Carl Zeiss Meditec's revenue is stable on a currency-adjusted basis, but adjusted EBITA margin decreased to 8.0% due to issues in China and softer investment in APAC. Guidance for full-year revenue and adjusted EBITA margin is provided, but no significant quantified surprises are disclosed.

The filing

Carl Zeiss Meditec Ag — Eqs News Carl Zeiss Meditec With Stable Reve

Read the RNS announcement →

How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.

Get filings like this every market day

The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.

Subscribe free →